Role of Vitamin D in Management of Diabetes and Unresolved Cardiovascular Diseases.
Study Goal
The researchers aimed to review the effects of Vitamin D therapy on cardiovascular diseases and diabetes, and explain the underlying mechanisms.
Results Summary
The study found that Vitamin D deficiency is linked to increased risks of death and heart disease, but meta-analyses of intervention trials showed no substantial changes in insulin sensitivity, lipid markers, or blood pressure.
Population
Humans (general population with Vitamin D deficiency and related diseases).
Effective Dosage
Not available
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Vitamin D | neutral | obesity | - | - | regulates | #1 |
Vitamin D | neutral | Renin-angiotensin system (RAS) | - | - | regulates | #2 |
Vitamin D | neutral | energy consumption | - | - | regulates | #3 |
Vitamin D | neutral | pancreatic cell function | - | - | regulates | #4 |
Vitamin D deficiency | neutral | diabetes | humans | - | has been associated with | #5 |
Vitamin D deficiency | neutral | asthma | humans | - | has been associated with | #6 |
Vitamin D deficiency | neutral | hyperlipidaemia | humans | - | has been associated with | #7 |
Vitamin D deficiency | neutral | pulmonary hypertension | humans | - | has been associated with | #8 |
Vitamin D deficiency | increase | death | - | - | linked to an elevated risk of | #9 |
Vitamin D deficiency | increase | heart disease | - | - | linked to an elevated risk of | #10 |
vitamin D intervention | no change | insulin sensitivity | - | no substantial changes | found no substantial changes in | #11 |
vitamin D intervention | no change | lipid markers | - | no substantial changes | found no substantial changes in | #12 |
vitamin D intervention | no change | blood pressure | - | no substantial changes | found no substantial changes in | #13 |
BACKGROUND: Vitamin D deficiency is becoming a widely recognized global health issue. Serum values of 25-(OH) vitamin D (<20 ng/ml) are used to identify vitamin D deficiency. By prompting vascular endothelial cells to activate their nuclear receptor in cardio-myocytes, Vitamin D regulates obesity, Renin-angiotensin system (RAS), energy consumption, and pancreatic cell function. Vitamin D deficiency has been associated with diabetes, asthma, hyperlipidaemia, and pulmonary hypertension in humans. METHODS: PubMed and Google Scholar databases were utilised to search the literature on vitamin D and related diseases. RESULT: It is also linked to an elevated risk of death and heart disease. On the other hand, metaanalyses of vitamin D intervention and trials have found no substantial changes in insulin sensitivity, lipid markers, or blood pressure, which result in the association between deficiency of vitamin D and cardiovascular disease. CONCLUSION: In this review, we present the most recent research on the effects of Vitamin D therapy on various cardiovascular diseases and diabetes, and explain the underlying mechanisms.